Come close and co-create: Proximities in pharmaceutical innovation networks
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Buch |
| Sprache: | English |
| Veröffentlicht: |
Rotterdam
Erasmus Univ. Rotterdam
2008
|
| Schriftenreihe: | Tinbergen Institute research series
434 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Zsf. in niederl. Sprache S. 125 - 128 |
| Beschreibung: | [14], 173 S. graph. Darst. |
| ISBN: | 9789051709186 |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV035178958 | ||
| 003 | DE-604 | ||
| 005 | 20090309 | ||
| 007 | t | ||
| 008 | 081125s2008 d||| m||| 00||| eng d | ||
| 020 | |a 9789051709186 |9 978-90-5170-918-6 | ||
| 035 | |a (OCoLC)276780609 | ||
| 035 | |a (DE-599)BVBBV035178958 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 100 | 1 | |a Phlippen, Sandra |d 1978- |e Verfasser |0 (DE-588)136747167 |4 aut | |
| 245 | 1 | 0 | |a Come close and co-create |b Proximities in pharmaceutical innovation networks |c Sandra Magdalenea Wilhelmina Phlippen |
| 264 | 1 | |a Rotterdam |b Erasmus Univ. Rotterdam |c 2008 | |
| 300 | |a [14], 173 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Tinbergen Institute research series |v 434 | |
| 500 | |a Zsf. in niederl. Sprache S. 125 - 128 | ||
| 502 | |a Zugl.: Rotterdam, Uni., Diss., 2008 | ||
| 650 | 7 | |a Biotechnische Industrie |2 stw | |
| 650 | 7 | |a Europa |2 stw | |
| 650 | 7 | |a Innovation |2 stw | |
| 650 | 7 | |a Organisationsverhalten |2 stw | |
| 650 | 7 | |a Regionale Konzentration |2 stw | |
| 650 | 4 | |a Pharmaceutical industry | |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 830 | 0 | |a Tinbergen Institute research series |v 434 |w (DE-604)BV004252095 |9 434 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016985743&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016985743 | ||
Datensatz im Suchindex
| _version_ | 1804138350855061504 |
|---|---|
| adam_text | COME CLOSE AND CO-CREATE PROXIMITIES IN PHARMACEUTICAL INNOVATION
NETWORKS B 360666 TABLE OF CONTENTS VOORWOORD (ACKNOWLEDGEMENTS IN
DUTCH) TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 1.1 MOTIVATION, AIM AND
SCOPE 1 1.2 INNOVATION STRATEGY OF THE FIRM 3 1.2.1 DYNAMIC CAPABILITIES
3 1.2.2 MAKE, BUY OR ALLY . 4 1.2.3 AVAILABILITY AND USABILITY OF
KNOWLEDGE 9 1.2.4 PROXIMITIES 10 1.3 EMPIRICAL SETTING: THE EUROPEAN
BIOPHARMACEUTICAL INDUSTRY 15 1.3.1 DRUG DEVELOPMENT PROCESS 16 1.3.2
HISTORICAL OVERVIEW 17 MOLECULAR BIOLOGY REVOLUTION 17 1 GENOMICS
REVOLUTION 19 1.4 OUTLINE OF THE BOOK 20 CHAPTER 2 PROXIMITIES IN THE
EUROPEAN BIOPHARMACEUTICAL INDUSTRY: REGIONAL CLUSTERS AND NETWORKS 2.1
INTRODUCTION 23 2.2 DATA 24 2.2 DATA - 24 2.2.1 DATA PREPARATION 24
2.2.2 CLUSTER IDENTIFICATION 25 2.3 GEOGRAPHICAL PROXIMITY: REGIONAL
CLUSTER DEVELOPMENT 26 2.3.1 IDENTIFYING THE MAIN CLUSTERS AND THE MAIN
ACTIVITIES 28 2.3.2 POSITIONING OF MAIN CLUSTERS IN THE EUROPEAN
NETWORK: RELATIONAL ATTRIBUTES , 34 2.3.3 TYPES OF CLUSTERS 40 2.4
RELATIONAL PROXIMITY: INTER-FIRM NETWORK DEVELOPMENT 42 2.4.1 LOCAL &
NON-LOCAL SEARCH IN THE NETWORK 42 2.4.2 LOCAL & NON-LOCAL SEARCH &
INNOVATION 43 TABLE OF CONTENTS 2.4.3 LOCAL LINKAGES AND NON-LOCAL
LINKAGES IN EXPLORATION AND IN EXPLOITATION NETWORKS 44 2.5 CONCLUDING
REMARKS 49 CHAPTER 3 COMPLEMENTARITIES AND THE R&D BOUNDARIES OF THE
FIRM: A PROJECT LEVEL STUDY ON PHARMACEUTICAL R&D STRATEGIES 3.1
INTRODUCTION 51 3.2 LITERATURE 53 3.3 EMPIRICAL SETTING: THE
PHARMACEUTICAL INDUSTRY 57 3.4 EMPIRICAL STRATEGY 58 3.4.1 DATA
SELECTION 60 3.4.2 BUILDING A RESEARCH PORTFOLIO 61 3.4.3 VARIABLES 61
3.5. RESULTS 65 3.5.1 EFFECT OF INDIVIDUAL PROJECT CHARACTERISTICS 65
3.5.2 CONDITIONS FOR COMPLEMENTARITIES 66 3.5.3 HOW DO COMPLEMENTARITIES
ARISE BETWEEN INTERNAL AND EXTERNAL PROJECTS? 72 3.6 CONCLUSIONS 75
CHAPTER 4 WHEN CLUSTERS BECOME NETWORKS: ALLIANCE FORMATION IN REGIONAL
CLUSTERS 4.1 INTRODUCTION 77 4.2 PRELIMINARY DATA VIEW 80 4.3 LITERATURE
& HYPOTHESES 87 4.3.1 LINK FORMATION 87 4.3.2 LOCAL LINK FORMATION 88
4.4 DATA AND METHODS 93 4.4.1 DATA 93 4.4.2 DEPENDENT VARIABLE 96
4.4.3 INDEPENDENT VARIABLES 96 4.4.4 ANALYSIS 99 4.5 RESULTS 100 4.5.1
THE NATURE OF KNOWLEDGE 101 4.5.2 RELATED VARIETY 101 4.5.3 TYPE OF
ORGANIZATIONS PRESENT 102 4.5.4 CLUSTER LIFE CYCLE 102 TABLE OF CONTENTS
4.6 DISCUSSION & CONCLUSION 103 CHAPTER 5 RADICAL INNOVATION AND NETWORK
EVOLUTION: THE EFFECT OF THE GENOMIC REVOLUTION ON THE EVOLUTION OF THE
PHARMACEUTICAL R&D NETWORK 5.1 INTRODUCTION 5.2 NETWORK EVOLUTION 5.2.1
LOCAL LINK FORMATION 5.2.2 DISTANT LINK-FORMATION 5.2.3 SMALL WORLDS 5.3
STRUCTURAL CHANGE 5.3.1 CLUSTERING COEFFICIENT 5.3.2 AVERAGE PATH-LENGTH
5.4 EXOGENOUS INFLUENCES ON STRUCTURAL NETWORK CHANGE 5.4.1 THE GENOMIC
REVOLUTION 5.5 EFFECTS OF THE RADICAL TECHNOLOGICAL CHANGE 5.5.1
STRUCTURAL CHANGE: UNCERTAINTY AND MUNIFICENCE AFTER THE GENOMIC
REVOLUTION 5.5.2 STRUCTURAL CHANGE: LOCAL CLUSTERING AND DISTANT
LINKAGES 5.6 DATA AND METHODS 5.7 RESULTS 5.7.1 STRUCTURAL CHANGE 5.8
DISCUSSION & INTERPRETATION 5.9 CONCLUSION 107 109 110 111 111 112 114
115 119 120 123 123 125 128 129 129 135 137 CHAPTER 6 CONCLUSION 6.1
GEOGRAPHICAL PROXIMITY 140 6.2 RELATIONAL PROXIMITY . ^ 141 6.3
COGNITIVE PROXIMITY 143 6.4 INTERACTION EFFECTS 144 POLICY IMPLICATIONS
145 BIBLIOGRAPHY 147 SAMENVATTING (SUMMARY IN DUTCH) 163
|
| adam_txt |
COME CLOSE AND CO-CREATE PROXIMITIES IN PHARMACEUTICAL INNOVATION
NETWORKS B 360666 TABLE OF CONTENTS VOORWOORD (ACKNOWLEDGEMENTS IN
DUTCH) TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 1.1 MOTIVATION, AIM AND
SCOPE 1 1.2 INNOVATION STRATEGY OF THE FIRM 3 1.2.1 DYNAMIC CAPABILITIES
3 1.2.2 MAKE, BUY OR ALLY . 4 1.2.3 AVAILABILITY AND USABILITY OF
KNOWLEDGE 9 1.2.4 PROXIMITIES 10 1.3 EMPIRICAL SETTING: THE EUROPEAN
BIOPHARMACEUTICAL INDUSTRY 15 1.3.1 DRUG DEVELOPMENT PROCESS 16 1.3.2
HISTORICAL OVERVIEW 17 MOLECULAR BIOLOGY REVOLUTION 17 1 GENOMICS
REVOLUTION 19 1.4 OUTLINE OF THE BOOK 20 CHAPTER 2 PROXIMITIES IN THE
EUROPEAN BIOPHARMACEUTICAL INDUSTRY: REGIONAL CLUSTERS AND NETWORKS 2.1
INTRODUCTION 23 2.2 DATA 24 2.2 DATA - 24 2.2.1 DATA PREPARATION 24
2.2.2 CLUSTER IDENTIFICATION 25 2.3 GEOGRAPHICAL PROXIMITY: REGIONAL
CLUSTER DEVELOPMENT 26 2.3.1 IDENTIFYING THE MAIN CLUSTERS AND THE MAIN
ACTIVITIES 28 2.3.2 POSITIONING OF MAIN CLUSTERS IN THE EUROPEAN
NETWORK: RELATIONAL ATTRIBUTES , 34 2.3.3 TYPES OF CLUSTERS 40 2.4
RELATIONAL PROXIMITY: INTER-FIRM NETWORK DEVELOPMENT 42 2.4.1 LOCAL &
NON-LOCAL SEARCH IN THE NETWORK 42 2.4.2 LOCAL & NON-LOCAL SEARCH &
INNOVATION 43 TABLE OF CONTENTS 2.4.3 LOCAL LINKAGES AND NON-LOCAL
LINKAGES IN EXPLORATION AND IN EXPLOITATION NETWORKS 44 2.5 CONCLUDING
REMARKS 49 CHAPTER 3 COMPLEMENTARITIES AND THE R&D BOUNDARIES OF THE
FIRM: A PROJECT LEVEL STUDY ON PHARMACEUTICAL R&D STRATEGIES 3.1
INTRODUCTION 51 3.2 LITERATURE 53 3.3 EMPIRICAL SETTING: THE
PHARMACEUTICAL INDUSTRY 57 3.4 EMPIRICAL STRATEGY 58 3.4.1 DATA
SELECTION 60 3.4.2 BUILDING A RESEARCH PORTFOLIO 61 3.4.3 VARIABLES 61
3.5. RESULTS 65 3.5.1 EFFECT OF INDIVIDUAL PROJECT CHARACTERISTICS 65
3.5.2 CONDITIONS FOR COMPLEMENTARITIES 66 3.5.3 HOW DO COMPLEMENTARITIES
ARISE BETWEEN INTERNAL AND EXTERNAL PROJECTS? " 72 3.6 CONCLUSIONS 75
CHAPTER 4 WHEN CLUSTERS BECOME NETWORKS: ALLIANCE FORMATION IN REGIONAL
CLUSTERS 4.1 INTRODUCTION 77 4.2 PRELIMINARY DATA VIEW 80 4.3 LITERATURE
& HYPOTHESES 87 4.3.1 LINK FORMATION 87 4.3.2 LOCAL LINK FORMATION 88
4.4 DATA AND METHODS 93 4.4.1 DATA " 93 4.4.2 DEPENDENT VARIABLE 96
4.4.3 INDEPENDENT VARIABLES 96 4.4.4 ANALYSIS 99 4.5 RESULTS ' 100 4.5.1
THE NATURE OF KNOWLEDGE 101 4.5.2 RELATED VARIETY 101 4.5.3 TYPE OF
ORGANIZATIONS PRESENT 102 4.5.4 CLUSTER LIFE CYCLE 102 TABLE OF CONTENTS
4.6 DISCUSSION & CONCLUSION 103 CHAPTER 5 RADICAL INNOVATION AND NETWORK
EVOLUTION: THE EFFECT OF THE GENOMIC REVOLUTION ON THE EVOLUTION OF THE
PHARMACEUTICAL R&D NETWORK 5.1 INTRODUCTION 5.2 NETWORK EVOLUTION 5.2.1
LOCAL LINK FORMATION 5.2.2 DISTANT LINK-FORMATION 5.2.3 SMALL WORLDS 5.3
STRUCTURAL CHANGE 5.3.1 CLUSTERING COEFFICIENT 5.3.2 AVERAGE PATH-LENGTH
5.4 EXOGENOUS INFLUENCES ON STRUCTURAL NETWORK CHANGE 5.4.1 THE GENOMIC
REVOLUTION 5.5 EFFECTS OF THE RADICAL TECHNOLOGICAL CHANGE 5.5.1
STRUCTURAL CHANGE: UNCERTAINTY AND MUNIFICENCE AFTER THE GENOMIC
REVOLUTION 5.5.2 STRUCTURAL CHANGE: LOCAL CLUSTERING AND DISTANT
LINKAGES 5.6 DATA AND METHODS 5.7 RESULTS 5.7.1 STRUCTURAL CHANGE 5.8
DISCUSSION & INTERPRETATION 5.9 CONCLUSION 107 109 110 111 111 112 114
115 119 120 123 123 125 128 129 129 135 137 CHAPTER 6 CONCLUSION 6.1
GEOGRAPHICAL PROXIMITY 140 6.2 RELATIONAL PROXIMITY . ^ 141 6.3
COGNITIVE PROXIMITY 143 6.4 INTERACTION EFFECTS 144 POLICY IMPLICATIONS
145 BIBLIOGRAPHY 147 SAMENVATTING (SUMMARY IN DUTCH) 163 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author | Phlippen, Sandra 1978- |
| author_GND | (DE-588)136747167 |
| author_facet | Phlippen, Sandra 1978- |
| author_role | aut |
| author_sort | Phlippen, Sandra 1978- |
| author_variant | s p sp |
| building | Verbundindex |
| bvnumber | BV035178958 |
| ctrlnum | (OCoLC)276780609 (DE-599)BVBBV035178958 |
| format | Thesis Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01597nam a2200397zcb4500</leader><controlfield tag="001">BV035178958</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090309 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">081125s2008 d||| m||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789051709186</subfield><subfield code="9">978-90-5170-918-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)276780609</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV035178958</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Phlippen, Sandra</subfield><subfield code="d">1978-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)136747167</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Come close and co-create</subfield><subfield code="b">Proximities in pharmaceutical innovation networks</subfield><subfield code="c">Sandra Magdalenea Wilhelmina Phlippen</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rotterdam</subfield><subfield code="b">Erasmus Univ. Rotterdam</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">[14], 173 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Tinbergen Institute research series</subfield><subfield code="v">434</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Zsf. in niederl. Sprache S. 125 - 128</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="a">Zugl.: Rotterdam, Uni., Diss., 2008</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biotechnische Industrie</subfield><subfield code="2">stw</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Europa</subfield><subfield code="2">stw</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Innovation</subfield><subfield code="2">stw</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Organisationsverhalten</subfield><subfield code="2">stw</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Regionale Konzentration</subfield><subfield code="2">stw</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Tinbergen Institute research series</subfield><subfield code="v">434</subfield><subfield code="w">(DE-604)BV004252095</subfield><subfield code="9">434</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016985743&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016985743</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV035178958 |
| illustrated | Illustrated |
| index_date | 2024-07-02T22:57:10Z |
| indexdate | 2024-07-09T21:26:48Z |
| institution | BVB |
| isbn | 9789051709186 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016985743 |
| oclc_num | 276780609 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | [14], 173 S. graph. Darst. |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Erasmus Univ. Rotterdam |
| record_format | marc |
| series | Tinbergen Institute research series |
| series2 | Tinbergen Institute research series |
| spelling | Phlippen, Sandra 1978- Verfasser (DE-588)136747167 aut Come close and co-create Proximities in pharmaceutical innovation networks Sandra Magdalenea Wilhelmina Phlippen Rotterdam Erasmus Univ. Rotterdam 2008 [14], 173 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Tinbergen Institute research series 434 Zsf. in niederl. Sprache S. 125 - 128 Zugl.: Rotterdam, Uni., Diss., 2008 Biotechnische Industrie stw Europa stw Innovation stw Organisationsverhalten stw Regionale Konzentration stw Pharmaceutical industry (DE-588)4113937-9 Hochschulschrift gnd-content Tinbergen Institute research series 434 (DE-604)BV004252095 434 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016985743&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Phlippen, Sandra 1978- Come close and co-create Proximities in pharmaceutical innovation networks Tinbergen Institute research series Biotechnische Industrie stw Europa stw Innovation stw Organisationsverhalten stw Regionale Konzentration stw Pharmaceutical industry |
| subject_GND | (DE-588)4113937-9 |
| title | Come close and co-create Proximities in pharmaceutical innovation networks |
| title_auth | Come close and co-create Proximities in pharmaceutical innovation networks |
| title_exact_search | Come close and co-create Proximities in pharmaceutical innovation networks |
| title_exact_search_txtP | Come close and co-create Proximities in pharmaceutical innovation networks |
| title_full | Come close and co-create Proximities in pharmaceutical innovation networks Sandra Magdalenea Wilhelmina Phlippen |
| title_fullStr | Come close and co-create Proximities in pharmaceutical innovation networks Sandra Magdalenea Wilhelmina Phlippen |
| title_full_unstemmed | Come close and co-create Proximities in pharmaceutical innovation networks Sandra Magdalenea Wilhelmina Phlippen |
| title_short | Come close and co-create |
| title_sort | come close and co create proximities in pharmaceutical innovation networks |
| title_sub | Proximities in pharmaceutical innovation networks |
| topic | Biotechnische Industrie stw Europa stw Innovation stw Organisationsverhalten stw Regionale Konzentration stw Pharmaceutical industry |
| topic_facet | Biotechnische Industrie Europa Innovation Organisationsverhalten Regionale Konzentration Pharmaceutical industry Hochschulschrift |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016985743&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV004252095 |
| work_keys_str_mv | AT phlippensandra comecloseandcocreateproximitiesinpharmaceuticalinnovationnetworks |